Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Myelination across the autism spectrum: therapeutic targeting of the oligodendrocyte lineage and myelination defects
    Published on 2025-08-28
    1 year ago
  • Targeting GPR3 as a novel approach for nicotine cessation therapeutic development
    Published on 2025-08-27
    1 year ago
  • Connectome-based encoding of subjective drug responses to acute oral methamphetamine
    Published on 2025-08-27
    1 year ago
  • Leveraging high-resolution brain imaging and (epi)genomic approaches to improve women’s mental health
    Published on 2025-08-26
    1 year ago
  • Cannabidiol prevents cognitive and social deficits in a male rat model of Alzheimer’s disease through CB1 activation and inflammation modulation
    Published on 2025-08-26
    1 year ago
  • Toward scalable biomarkers: the promise of sleep wearables in neurodevelopmental research
    Published on 2025-08-26
    1 year ago
  • For those with schizophrenia, does cannabidiol make cannabis use safer?
    Published on 2025-08-26
    1 year ago
« Previous 1 … 50 51 52 53 54 … 143 Next »
Journal of Psychopharmacology
  • Chronic Cannabis users exhibit altered oscillatory dynamics and functional connectivity serving visuospatial processing
    Published on 2024-08-01
    2 years ago
  • A framework for assessment of adverse events occurring in psychedelic-assisted therapies
    Published on 2024-07-31
    2 years ago
  • From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions
    Published on 2024-07-30
    2 years ago
  • Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”
    Published on 2024-07-28
    2 years ago
  • No evidence that post-training dopamine D2 receptor agonism affects fear generalization in male rats
    Published on 2024-07-28
    2 years ago
  • Acute methamphetamine and alcohol usage alters gaze behaviour during driving: A randomised, double-blind, placebo-controlled study
    Published on 2024-07-28
    2 years ago
  • Severe neutropenia unrelated to clozapine in patients receiving clozapine
    Published on 2024-07-23
    2 years ago
« Previous 1 … 50 51 52 53 54 … 154 Next »
European Neuropsychopharmacology
  • Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents
    Published on 2024-04-21
    2 years ago
  • Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials
    Published on 2024-04-21
    2 years ago
  • Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis
    Published on 2024-04-20
    2 years ago
  • Prescribing therapeutic apps within National Health Services: The critical role of evaluation and monitoring
    Published on 2024-04-20
    2 years ago
  • Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression
    Published on 2024-04-20
    2 years ago
  • Antidepressant use in bipolar disorder: Shifting focus from ‘Whether’ to ‘Whom’
    Published on 2024-04-19
    2 years ago
  • Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials
    Published on 2024-04-04
    2 years ago
« Previous 1 … 50 51 52 53 54 … 170 Next »

   Pharma Pub